Nuradar 600 mg Tablets
PDF Leaflet Revision Date: 12 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in antiretroviral treatment experienced adult patients.
Dosage (summary)
600 mg twice daily with 100 mg ritonavir, taken with food.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Key Drug Interactions
- CYP3A inhibitors
- Rifampicin
- St. John's Wort
Contraindications
- Hypersensitivity to darunavir
- Severe hepatic impairment
- Concomitant use with certain CYP3A substrates
Common side effects
- Rash
- Diarrhea
- Nausea
- Fatigue
- Headache
Counselling Points
- Take with food
- Do not alter doses without consulting a doctor
- Monitor for signs of severe skin reactions
Serious warnings
- Severe skin reactions
- Immune reactivation syndrome
- Increased bleeding in hemophiliacs
Important Disclaimer
The Nuradar 600 mg Tablets professional information leaflet below is the property of Aurobindo Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
